- Agilgen is a next-generation biotechnology company transforming drug discovery through artificial intelligence.
- We integrate AI-guided molecular design with solid-state engineering to strengthen both binding performance and manufacturability robustness across development milestones.
- Our approach bridges discovery optimization and CMC-critical stability evaluation, enabling more confident development decisions prior to scale-up, tech transfer, and regulatory submission.
Two Core Services:
AI-assisted molecular design, docking optimization, ADME/Tox prediction, and lead refinement.
Solid-State Engineering
We apply solid-state engineering to strengthen stability, enhance manufacturability, and support CMC-critical decisions for clinical-stage small molecules.